Skip to main content
. Author manuscript; available in PMC: 2017 Mar 9.
Published in final edited form as: Antivir Ther. 2015;20(7):753–761. doi: 10.3851/IMP2945

Table 2.

NIs’ prescription among ILI cases included between 2009 and 2013, 35188 cases seen in GPs’ consultation (French GPs’ Sentinels database) and 1854 seen in GPs’ and paediatricians’ consultation ≤ 48h after onset of symptoms (GROG network database)

2009/2010 2010/2011 2011/2012 2012/2013 Total
Sentinelles GPs’ database *
N=35188
NIs’ prescription, n (%) 1440 (16.1) 493 (6.5) 402 (8.2) 510 (4.6) 2845 (8.8)
among ILI patients with at least one influenza risk factor***, n (%) 410 (61.1) 176 (34.5) 146 (23.6) 187 (19.6) 919 (33.4)
among ILI patients without any influenza risk factor***, n (%) 991 (12.3) 309 (4.4) 249 (5.9) 314 (3.2) 1863 (6.4)
Grog GPs database **
N=894
NIs’ prescription, n (%) 61 (16.8) 15 (8.3) 14 (11.5) 24 (10.7) 114 (12.8)
among ILI patients with at least one influenza risk factor***, n (%) 17 (43.6) 3 (21.4) 6 (26.1) 6 (25) 32 (32)
among ILI patients without any influenza risk factor***, n (%) 27 (15.3) 11 (6.6) 8 (8.1) 18 (9.3) 64 (10.1)
Grog paediatricians’ database **
N=960
NIs’ prescription, n (%) 57 (15.7) 18 (9.2) 16 (9.8) 15 (6.4) 106 (11.1)
among ILI patients with at least one influenza risk factor***, n (%) 9 (50) 5 (55.6) 0 (0) 0 (0) 14 (40)
among ILI patients without any influenza risk factor***, n (%) 35 (17.2) 13 (7.0) 16 (10.1) 14 (6.2) 78 (10.1)
*

All ILI cases seen in consultation

**

ILI cases seen in consultation ≤ 48h after onset of symptoms

***

Presence of a severe influenza risk factor was defined by patients with at least one of the following characteristics: age ≥ 65 years old, chronic underlying disease, obesity defined as BMI ≥ 40, and pregnancy